NYSE:THQ - Tekla Healthcare Opportunities Fund Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$17.62 -0.10 (-0.56 %)
(As of 07/16/2018 04:00 PM ET)
Previous Close$17.72
Today's Range$17.58 - $17.78
52-Week Range$16.02 - $19.00
Volume117,234 shs
Average Volume133,313 shs
Market Capitalization$773.57 million
P/E RatioN/A
Dividend Yield7.68%
Beta1.05
Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund. The Fund's investment objective is to seek current income and long-term capital appreciation through investments in the United States and non-United States companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. It invests primarily in securities of public and private companies. It focuses on investing in private companies and other restricted securities, including private investments in public equity and venture capital investments, if these securities would comprise approximately 10% or less of managed assets. It invests in sub-sectors, such as biotechnology, healthcare equipment and supplies, healthcare providers and services, healthcare technology, life sciences tools and services, pharmaceuticals, real estate investment trusts, real estate management and development. Tekla Capital Management LLC is the investment advisor of the Fund.

Receive THQ News and Ratings via Email

Sign-up to receive the latest news and ratings for THQ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSE:THQ
CUSIPN/A
Phone+1-617-7728500

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares43,880,000
Market Cap$773.57

The Truth About Cryptocurrencies

Tekla Healthcare Opportunities Fund (NYSE:THQ) Frequently Asked Questions

What is Tekla Healthcare Opportunities Fund's stock symbol?

Tekla Healthcare Opportunities Fund trades on the New York Stock Exchange (NYSE) under the ticker symbol "THQ."

How often does Tekla Healthcare Opportunities Fund pay dividends? What is the dividend yield for Tekla Healthcare Opportunities Fund?

Tekla Healthcare Opportunities Fund announced a monthly dividend on Wednesday, July 11th. Shareholders of record on Friday, July 20th will be paid a dividend of $0.1125 per share on Tuesday, July 31st. This represents a $1.35 annualized dividend and a dividend yield of 7.66%. The ex-dividend date of this dividend is Thursday, July 19th. View Tekla Healthcare Opportunities Fund's Dividend History.

What is the consensus analysts' recommendation for Tekla Healthcare Opportunities Fund?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tekla Healthcare Opportunities Fund in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are Tekla Healthcare Opportunities Fund's key executives?

Tekla Healthcare Opportunities Fund's management team includes the folowing people:
  • Daniel R. Omstead Ph.D., President, Trustee (Age 64)
  • Laura Woodward CPA, Chief Compliance Officer, Treasurer, Secretary (Age 49)
  • Michael W. Bonney, Independent Trustees (Age 59)
  • Rakesh K. Jain Ph.D., Independent Trustees (Age 67)
  • Oleg M. Pohotsky, Independent Trustees (Age 70)
  • William S. Reardon CPA, Independent Trustees (Age 71)
  • Uwe E. Reinhardt Ph.D., Independent Trustees (Age 80)

Has Tekla Healthcare Opportunities Fund been receiving favorable news coverage?

News articles about THQ stock have trended somewhat positive this week, Accern Sentiment reports. The research group rates the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Tekla Healthcare Opportunities Fund earned a news sentiment score of 0.09 on Accern's scale. They also gave headlines about the company an impact score of 45.62 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

How do I buy shares of Tekla Healthcare Opportunities Fund?

Shares of THQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tekla Healthcare Opportunities Fund's stock price today?

One share of THQ stock can currently be purchased for approximately $17.62.

How big of a company is Tekla Healthcare Opportunities Fund?

Tekla Healthcare Opportunities Fund has a market capitalization of $773.57 million.

How can I contact Tekla Healthcare Opportunities Fund?

Tekla Healthcare Opportunities Fund's mailing address is 100 Federal St Fl 19, BOSTON, MA 02110-1831, United States. The company can be reached via phone at +1-617-7728500.


MarketBeat Community Rating for Tekla Healthcare Opportunities Fund (NYSE THQ)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  19 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  36
MarketBeat's community ratings are surveys of what our community members think about Tekla Healthcare Opportunities Fund and other stocks. Vote "Outperform" if you believe THQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe THQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.